| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy.
|
Eur J Heart Fail
|
2010
|
3.90
|
|
2
|
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies.
|
N Engl J Med
|
2016
|
3.40
|
|
3
|
Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
|
Circulation
|
2010
|
2.45
|
|
4
|
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
|
Nature
|
2012
|
2.27
|
|
5
|
Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
|
Circulation
|
2004
|
2.10
|
|
6
|
Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion.
|
Basic Res Cardiol
|
2010
|
1.88
|
|
7
|
Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
|
Circ Res
|
2005
|
1.86
|
|
8
|
Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
|
Circulation
|
2003
|
1.81
|
|
9
|
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.
|
J Clin Invest
|
2013
|
1.80
|
|
10
|
Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
|
Circ Res
|
2007
|
1.77
|
|
11
|
The myocardial JAK/STAT pathway: from protection to failure.
|
Pharmacol Ther
|
2008
|
1.72
|
|
12
|
Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.
|
Circulation
|
2004
|
1.69
|
|
13
|
Predictors of outcome in 176 South African patients with peripartum cardiomyopathy.
|
Heart
|
2012
|
1.68
|
|
14
|
Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies.
|
Cell Stem Cell
|
2011
|
1.67
|
|
15
|
Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice.
|
Circ Res
|
2007
|
1.64
|
|
16
|
Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine.
|
J Am Coll Cardiol
|
2007
|
1.63
|
|
17
|
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
|
2009
|
1.61
|
|
18
|
Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.
|
Eur J Heart Fail
|
2014
|
1.52
|
|
19
|
Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.
|
Am J Obstet Gynecol
|
2008
|
1.51
|
|
20
|
MLP: a stress sensor goes nuclear.
|
J Mol Cell Cardiol
|
2009
|
1.45
|
|
21
|
Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
|
Circulation
|
2004
|
1.45
|
|
22
|
Sex determination in Drosophila melanogaster and Musca domestica converges at the level of the terminal regulator doublesex.
|
Dev Genes Evol
|
2003
|
1.43
|
|
23
|
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
|
2011
|
1.40
|
|
24
|
Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients.
|
Eur Heart J
|
2005
|
1.39
|
|
25
|
Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc.
|
Proc Natl Acad Sci U S A
|
2005
|
1.36
|
|
26
|
Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy.
|
Eur J Heart Fail
|
2008
|
1.29
|
|
27
|
Survival pathways in hypertrophy and heart failure: the gp130-STAT axis.
|
Basic Res Cardiol
|
2007
|
1.26
|
|
28
|
Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade.
|
J Am Coll Cardiol
|
2011
|
1.20
|
|
29
|
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
|
Basic Res Cardiol
|
2013
|
1.20
|
|
30
|
Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes.
|
Eur Heart J
|
2010
|
1.14
|
|
31
|
EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM.
|
Eur J Heart Fail
|
2014
|
1.13
|
|
32
|
Long-term outcome of peripartum cardiomyopathy in a population with high seropositivity for human immunodeficiency virus.
|
Int J Cardiol
|
2009
|
1.08
|
|
33
|
Small molecule-mediated refolding and activation of myosin motor function.
|
Elife
|
2014
|
1.06
|
|
34
|
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
|
Eur Heart J
|
2013
|
1.06
|
|
35
|
Comparison of the American PPCM Registry Data With International Registries.
|
J Am Coll Cardiol
|
2016
|
1.05
|
|
36
|
Role of interleukin-6 for LV remodeling and survival after experimental myocardial infarction.
|
FASEB J
|
2003
|
1.05
|
|
37
|
Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II.
|
Circulation
|
2002
|
1.05
|
|
38
|
STAT3 and cardiac remodeling.
|
Heart Fail Rev
|
2011
|
1.01
|
|
39
|
Effects of anesthesia on diastolic function in mice assessed by echocardiography.
|
Echocardiography
|
2005
|
1.00
|
|
40
|
Stretch-inducible expression of the angiogenic factor CCN1 in vascular smooth muscle cells is mediated by Egr-1.
|
J Biol Chem
|
2004
|
0.99
|
|
41
|
Mitochondrial biogenesis and PGC-1α deacetylation by chronic treadmill exercise: differential response in cardiac and skeletal muscle.
|
Basic Res Cardiol
|
2011
|
0.98
|
|
42
|
STAT3, a key regulator of cell-to-cell communication in the heart.
|
Cardiovasc Res
|
2014
|
0.97
|
|
43
|
Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions.
|
Circulation
|
2006
|
0.96
|
|
44
|
Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.
|
Eur J Heart Fail
|
2014
|
0.95
|
|
45
|
Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress.
|
Cardiovasc Res
|
2014
|
0.95
|
|
46
|
SH3P7/mAbp1 deficiency leads to tissue and behavioral abnormalities and impaired vesicle transport.
|
EMBO J
|
2006
|
0.94
|
|
47
|
Transcoronary delivery of bone marrow cells to the infarcted murine myocardium: feasibility, cellular kinetics, and improvement in cardiac function.
|
Basic Res Cardiol
|
2006
|
0.94
|
|
48
|
Effects of chronic SDMA infusion on glomerular filtration rate, blood pressure, myocardial function and renal histology in C57BL6/J mice.
|
Nephrol Dial Transplant
|
2013
|
0.93
|
|
49
|
Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC.
|
Eur J Heart Fail
|
2011
|
0.92
|
|
50
|
Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator.
|
Circulation
|
2010
|
0.91
|
|
51
|
Reviewing peripartum cardiomyopathy: current state of knowledge.
|
Future Cardiol
|
2009
|
0.91
|
|
52
|
Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.
|
Circulation
|
2013
|
0.89
|
|
53
|
Functional microRNA library screening identifies the hypoxamir miR-24 as a potent regulator of smooth muscle cell proliferation and vascularization.
|
Antioxid Redox Signal
|
2013
|
0.88
|
|
54
|
Prolactin: a new therapeutic target in peripartum cardiomyopathy.
|
Heart
|
2010
|
0.88
|
|
55
|
STAT3 regulation of and by microRNAs in development and disease.
|
JAKSTAT
|
2012
|
0.88
|
|
56
|
Protective Function of STAT3 in CVB3-Induced Myocarditis.
|
Cardiol Res Pract
|
2012
|
0.87
|
|
57
|
Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure.
|
Eur J Heart Fail
|
2007
|
0.87
|
|
58
|
Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
|
Cardiovasc Res
|
2011
|
0.86
|
|
59
|
Evaluation of Tissue Doppler Tei index for global left ventricular function in mice after myocardial infarction: comparison with Pulsed Doppler Tei index.
|
Eur J Echocardiogr
|
2005
|
0.86
|
|
60
|
HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
|
Cardiovasc Res
|
2013
|
0.86
|
|
61
|
Circulating microparticles as indicators of peripartum cardiomyopathy.
|
Eur Heart J
|
2012
|
0.85
|
|
62
|
Haematopoietic stem cells improve cardiac function after infarction without permanent cardiac engraftment.
|
Eur J Heart Fail
|
2005
|
0.85
|
|
63
|
Gendered innovation in cardiovascular science: implementation of sex and gender into clinical and biomedical research.
|
Thorac Cardiovasc Surg
|
2013
|
0.83
|
|
64
|
Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload.
|
PLoS One
|
2011
|
0.83
|
|
65
|
Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: role of beta-catenin transduction and cell dose.
|
J Mol Cell Cardiol
|
2008
|
0.81
|
|
66
|
Interaction of the heart and its close and distant neighbours: report of the Meeting of the ESC Working Groups Myocardial Function and Cellular Biology.
|
Cardiovasc Res
|
2013
|
0.81
|
|
67
|
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure.
|
PLoS One
|
2012
|
0.81
|
|
68
|
The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro.
|
Cardiovasc Res
|
2009
|
0.81
|
|
69
|
Generation of bioartificial heart tissue by combining a three-dimensional gel-based cardiac construct with decellularized small intestinal submucosa.
|
Tissue Eng Part A
|
2013
|
0.80
|
|
70
|
Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports.
|
J Med Case Rep
|
2010
|
0.80
|
|
71
|
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models.
|
Eur J Heart Fail
|
2014
|
0.80
|
|
72
|
MiRNA-21: a key to controlling the cardiac fibroblast compartment?
|
Cardiovasc Res
|
2009
|
0.80
|
|
73
|
Peripartum cardiomyopathy: update 2012.
|
Curr Opin Crit Care
|
2013
|
0.79
|
|
74
|
Management of peripartum cardiomyopathy.
|
Curr Heart Fail Rep
|
2008
|
0.78
|
|
75
|
Disease-modifying mutations in familial hypertrophic cardiomyopathy: complexity from simplicity.
|
Circulation
|
2008
|
0.78
|
|
76
|
Cardiovascular disorders in pregnancy: diagnosis and management.
|
Best Pract Res Clin Obstet Gynaecol
|
2013
|
0.78
|
|
77
|
Epo deficiency alters cardiac adaptation to chronic hypoxia.
|
Respir Physiol Neurobiol
|
2013
|
0.77
|
|
78
|
The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
|
Immunobiology
|
2013
|
0.77
|
|
79
|
Left bundle branch block during pregnancy as a sign of imminent peripartum cardiomyopathy.
|
Eur Heart J
|
2011
|
0.77
|
|
80
|
Moderate and severe periodontitis are independent risk factors associated with low cardiorespiratory fitness in sedentary non-smoking men aged between 45 and 65 years.
|
J Clin Periodontol
|
2013
|
0.76
|
|
81
|
Marfan syndrome and pregnancy:monitoring and management.
|
Eur Heart J
|
2015
|
0.75
|
|
82
|
ACE inhibition improves cardiac force generation after myocardial infarction.
|
J Mol Cell Cardiol
|
2002
|
0.75
|
|
83
|
Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy.
|
Oncotarget
|
2011
|
0.75
|
|
84
|
'Social freezing' of women's eggs.
|
Eur Heart J
|
2015
|
0.75
|
|
85
|
Underestimated risk for life-threatening ventricular arrhythmias in newly diagnosed peripartum cardiomyopathy?
|
Eur Heart J
|
2015
|
0.75
|
|
86
|
Pregnancy hormones in cardiovascular disease.
|
Eur Heart J
|
2015
|
0.75
|
|
87
|
Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progression.
|
JCI Insight
|
2017
|
0.75
|
|
88
|
A management algorithm for acute heart failure in pregnancy. The Hannover experience.
|
Eur Heart J
|
2015
|
0.75
|
|
89
|
[Cardiovascular disease in pregnancy].
|
Dtsch Med Wochenschr
|
2016
|
0.75
|